These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29460033)

  • 1. Factors associated with improved outcomes for metastatic inflammatory breast cancer patients.
    Weiss A; Menen RS; Lin HY; Shen Y; Rosso KJ; Shaitelman S; Woodward W; Valero V; Ueno NT; Bedrosian I; Babiera G
    Breast Cancer Res Treat; 2018 Jun; 169(3):615-623. PubMed ID: 29460033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
    Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
    BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer.
    van Uden DJP; van Maaren MC; Bult P; Strobbe LJA; van der Hoeven JJM; Blanken-Peeters CFJM; Siesling S; de Wilt JHW
    Breast Cancer Res Treat; 2019 Jul; 176(1):217-226. PubMed ID: 30972613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
    Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
    Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
    van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
    Breast Cancer Res; 2019 Oct; 21(1):113. PubMed ID: 31623649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory breast cancer outcomes by breast cancer subtype: a population-based study.
    Wu SG; Zhang WW; Wang J; Dong Y; Sun JY; Chen YX; He ZY
    Future Oncol; 2019 Feb; 15(5):507-516. PubMed ID: 30378451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying factors that impact survival among women with inflammatory breast cancer.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
    Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
    Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME).
    Dano D; Lardy-Cleaud A; Monneur A; Quenel-Tueux N; Levy C; Mouret-Reynier MA; Coudert B; Mailliez A; Ferrero JM; Guiu S; Campone M; de La Motte Rouge T; Petit T; Pistilli B; Dalenc F; Simon G; Lerebours F; Chabaud S; Bertucci F; Gonçalves A
    ESMO Open; 2021 Aug; 6(4):100220. PubMed ID: 34303929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of CNS metastases and survival in patients with inflammatory breast cancer.
    Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
    Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory breast cancer in the Netherlands; improved survival over the last decades.
    van Uden DJ; Bretveld R; Siesling S; de Wilt JH; Blanken-Peeters CF
    Breast Cancer Res Treat; 2017 Apr; 162(2):365-374. PubMed ID: 28138891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study.
    Parrish KM; Thomas SM; Cartwright SB; van den Bruele AB; Zasloff R; DiLalla GA; DiNome ML; Menendez CS; Rosenberger LH; Woriax HE; Hwang ES; Plichta JK; Chiba A
    Ann Surg Oncol; 2024 Nov; 31(12):8057-8067. PubMed ID: 39158638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer.
    van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; Stam MR; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
    Surg Oncol; 2020 Jun; 33():43-50. PubMed ID: 32561098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database.
    Liu YL; Wang DW; Yang ZC; Ma R; Li Z; Suo W; Zhao Z; Li ZW
    Breast Cancer Res Treat; 2019 Nov; 178(2):379-388. PubMed ID: 31414242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers.
    Kai M; Kogawa T; Liu DD; Fouad TM; Kai K; Niikura N; Hsu L; Willey JS; Theriault RL; Valero V; Ueno NT
    Clin Breast Cancer; 2015 Feb; 15(1):37-42. PubMed ID: 25258308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role and indications of aggressive locoregional therapy in metastatic inflammatory breast cancer.
    Yan Y; Tang L; Tong W; Zhou J
    Sci Rep; 2016 May; 6():25874. PubMed ID: 27174789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory breast cancer appearance at presentation is associated with overall survival.
    Balema W; Liu D; Shen Y; El-Zein R; Debeb BG; Kai M; Overmoyer B; Miller KD; Le-Petross HT; Ueno NT; Woodward WA
    Cancer Med; 2021 Sep; 10(18):6261-6272. PubMed ID: 34327874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should breast surgery be considered for patients with de novo metastatic inflammatory breast cancer?
    Drapalik LM; Shenk R; Rock L; Simpson A; Amin AL; Miller ME
    Am J Surg; 2024 Jul; 233():52-60. PubMed ID: 38458830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of and survival following brain metastases among women with inflammatory breast cancer.
    Dawood S; Ueno NT; Valero V; Andreopoulou E; Hsu L; Lara J; Woodward W; Buchholz TA; Hortobagyi GN; Cristofanilli M
    Ann Oncol; 2010 Dec; 21(12):2348-2355. PubMed ID: 20439340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.